Compare Johnson & Johnson (JNJ) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Vipshop Holdings Ltd - ADR — how do they compare? Johnson & Johnson trades at $250.83 (market cap $598.96B), while Vipshop Holdings Ltd - ADR trades at $14.63 (market cap $7.01B). The key difference: Johnson & Johnson is far larger — about 85.4× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.25%). Which is the better fit depends on your goals.
| JNJ | VIPS | |
|---|---|---|
Market Cap | $598.96B | $7.01B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $20.68 |
52-Week Low | $164.36 | $12.92 |
Enterprise Value | $631.90B | $3.60B |
Dividend Yield | 2.15% | 4.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
Vipshop Holdings (VIPS) trades at $14.69, up 1.31% with a bullish technical signal. The stock shows strong fundamentals with a low P/E of 6.66 and robust profitability metrics including 18.43% ROE. Recent Q1 2026 earnings met expectations with management focusing on outlet strategy expansion through REIT spinoffs to drive growth.
The outlook remains positive with 53.57% analyst buy ratings supporting valuation upside potential. Key risks include Chinese consumer spending volatility and competitive e-commerce pressures. Revenue stabilization and margin improvements in 2026 projections suggest recovery potential after recent declines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
